Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy
NCT ID: NCT05560581
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
94 participants
INTERVENTIONAL
2022-11-07
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After a screening for eligibility, participants will be randomly assigned to intervention and control group. At baseline, participants attend a laboratory session where they are assessed for current psychiatric disorders and further relevant psychological variables. They will then either participate in the digital self-efficacy training combined with EMA (intervention group) or in EMA only (control group). Both will be conducted via a smartphone app. Subsequently, participants will be asked to fill in post questionnaires at three different time points: after having finished app usage, one month later, and after the beginning of the subsequent psychotherapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Psychotherapy-informed Self-help and Paraprofessional Training in a Naturalistic Setting
NCT06017414
Prevention of Mental Disorders Through Self-efficacy Interventions
NCT06738953
Agentic Self-view as Common Factor in Psychotherapy - Self-efficacy in the Treatment of Inpatients Over the Course of Time
NCT05594160
Effectiveness of an Ecological Momentary Emotion Regulation Intervention
NCT06311136
Feasibility of an Avatar-Led and ACT-Based App for Adjunctive Psychotherapy in In- and Outpatients: Virtual Coach App
NCT05010447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Participants will receive an one-week digital self-efficacy training (3x/day) and an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).
Digital self-efficacy training
Prior to the app participation, participants will receive psychoeducation on self-efficacy and will be instructed to define two autobiographical self-efficacy memories (own achievements, e.g., completion of an exam, success in a sporting event). During the week of app participation, they will be prompted three times per day and asked to perform an imagination task. Step by step, they will recall one of their autobiographic self-efficacy memories and focus on their character traits and abilities that were relevant for their achievement.
Ecological Momentary Assessment
Participants will receive questions on mood and social/virtual contacts 3 times per day.
Control group
Participants will receive an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).
Ecological Momentary Assessment
Participants will receive questions on mood and social/virtual contacts 3 times per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital self-efficacy training
Prior to the app participation, participants will receive psychoeducation on self-efficacy and will be instructed to define two autobiographical self-efficacy memories (own achievements, e.g., completion of an exam, success in a sporting event). During the week of app participation, they will be prompted three times per day and asked to perform an imagination task. Step by step, they will recall one of their autobiographic self-efficacy memories and focus on their character traits and abilities that were relevant for their achievement.
Ecological Momentary Assessment
Participants will receive questions on mood and social/virtual contacts 3 times per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-65
* waiting for psychiatric assessment/treatment (being on waitlist)
* sufficient knowledge of the German language
* smartphone user
* internet access via smartphone
* internet access at home (laptop, tablet, or computer)
Exclusion Criteria
* acute suicidality
* acute psychotic symptoms
* substance addiction
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Psychiatric University Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Judith Rohde, MD
Clinician Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Judith Rohde, MD
Role: PRINCIPAL_INVESTIGATOR
Psychiatric University Hospital Zurich, University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Integrated Psychiatry Winterthur
Winterthur, , Switzerland
Psychiatric University Hospital
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jochen Binder
Role: primary
Judith Rohde
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SeApp III
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.